Impact of comorbidity burden on renal cell carcinoma prognosis: A Danish nationwide cohort study

Trine Allerslev Horsbøll; Susanne Oksbjerg Dalton; Jane Christensen; Astrid Petersen; Nessn H. Azawi; Frede Donskov; Ole Andersen; Mette Nørgaard; Lars Lund

doi:10.1200/JCO.2021.39.6_suppl.360

Impact of comorbidity burden on renal cell carcinoma prognosis: A Danish nationwide cohort study

Trine Allerslev Horsbøll, Susanne Oksbjerg Dalton, Jane Christensen, Astrid Petersen, Nessn H. Azawi, Frede Donskov, Ole Andersen, Mette Nørgaard, Lars Lund

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Abstract

Background: The incidence of renal cell carcinoma is increasing worldwide and have a 5-year relative survival rates of around 75%. Comorbidity has been found to be associated with complications and mortality after renal cancer surgery. No studies have focused on comorbidity as a prognostic factor in a nationwide cohort of patients with renal cell carcinoma with long-term follow-up. Purpose: The primary aim was to evaluate the prognostic impact of comorbidity on survival in older (≥70 years) and younger (

Original language	English
Journal	Journal of Clinical Oncology
Volume	39
Issue number	6 Suppl.
Pages (from-to)	360
Number of pages	1
ISSN	0732-183X
DOIs	https://doi.org/10.1200/JCO.2021.39.6_suppl.360
Publication status	Published - 2021
Event	2021 Genitourinary Cancers Symposium - Virtual Meeting Duration: 11 Feb 2021 → 13 Feb 2021

Conference

Conference	2021 Genitourinary Cancers Symposium
Location	Virtual Meeting
Period	11/02/2021 → 13/02/2021

Access to Document

10.1200/JCO.2021.39.6_suppl.360

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

@article{9575da9364ee466eaf71ba4be0d75b91,

title = "Impact of comorbidity burden on renal cell carcinoma prognosis: A Danish nationwide cohort study",

abstract = "Background: The incidence of renal cell carcinoma is increasing worldwide and have a 5-year relative survival rates of around 75%. Comorbidity has been found to be associated with complications and mortality after renal cancer surgery. No studies have focused on comorbidity as a prognostic factor in a nationwide cohort of patients with renal cell carcinoma with long-term follow-up. Purpose: The primary aim was to evaluate the prognostic impact of comorbidity on survival in older (≥70 years) and younger (",

author = "Horsb{\o}ll, {Trine Allerslev} and Dalton, {Susanne Oksbjerg} and Jane Christensen and Astrid Petersen and Azawi, {Nessn H.} and Frede Donskov and Ole Andersen and Mette N{\o}rgaard and Lars Lund",

year = "2021",

doi = "10.1200/JCO.2021.39.6_suppl.360",

language = "English",

volume = "39",

pages = "360",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "6 Suppl.",

note = "2021 Genitourinary Cancers Symposium ; Conference date: 11-02-2021 Through 13-02-2021",

}

TY - ABST

T1 - Impact of comorbidity burden on renal cell carcinoma prognosis

T2 - 2021 Genitourinary Cancers Symposium

AU - Horsbøll, Trine Allerslev

AU - Dalton, Susanne Oksbjerg

AU - Christensen, Jane

AU - Petersen, Astrid

AU - Azawi, Nessn H.

AU - Donskov, Frede

AU - Andersen, Ole

AU - Nørgaard, Mette

AU - Lund, Lars

PY - 2021

Y1 - 2021

N2 - Background: The incidence of renal cell carcinoma is increasing worldwide and have a 5-year relative survival rates of around 75%. Comorbidity has been found to be associated with complications and mortality after renal cancer surgery. No studies have focused on comorbidity as a prognostic factor in a nationwide cohort of patients with renal cell carcinoma with long-term follow-up. Purpose: The primary aim was to evaluate the prognostic impact of comorbidity on survival in older (≥70 years) and younger (

AB - Background: The incidence of renal cell carcinoma is increasing worldwide and have a 5-year relative survival rates of around 75%. Comorbidity has been found to be associated with complications and mortality after renal cancer surgery. No studies have focused on comorbidity as a prognostic factor in a nationwide cohort of patients with renal cell carcinoma with long-term follow-up. Purpose: The primary aim was to evaluate the prognostic impact of comorbidity on survival in older (≥70 years) and younger (

U2 - 10.1200/JCO.2021.39.6_suppl.360

DO - 10.1200/JCO.2021.39.6_suppl.360

M3 - Conference abstract in journal

SN - 0732-183X

VL - 39

SP - 360

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 6 Suppl.

Y2 - 11 February 2021 through 13 February 2021

ER -